The abbreviations used are dCTP, deoxycytidine triphosphate; LET, linear energy transfer; mRb, mouse retinoblastoma gene; P2-M, &microglobulin; Rb, retinoblastoma gene. 
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Many tumor suppressor gene products are known to play critical roles in the control of normal cell growth and the maintenance of genomic stability (1). The p53 and retinoblastoma (Rb3) genes are the tumor suppressor genes that have been studied most extensively. Gene alterations, such as deletion of the entire gene or missense point mutations, are known to result in uncontrolled cell proliferation, which contributes to malignancy (2,3). Alterations in p53 are ~ the most common (about 50%) molecular abnormalities described to date in huinan neoplasias ( 
4-6).
Retinoblastoma is a form of human childhood retinal cancer that occurs with a frequency of 1 in 20,000 newborns (7,8). There are several "Rb-gene-related" tumors, including retinoblastoma (9), osteosarcoma (lo), sarcomas (1 l), small-cell lung carcinoma (12) , non-smallcell lung cancer (131, carcinoma of the breast (14), ovarian carcinoma (15), and leukemia (16) .
Wild-type p53 is an unstable protein with a very short cellular half-life (15-30 min) so its level in normal cells is very low (1 1,12). In responding to the DNA damage-inducing agents such as radiation, cells accumulate p53 protein. Elevated levels of p53 can cause either rapid induction of G1 arrest (allowing cells to undergo repair) or apoptosis (1). Under conditions that threaten the integrity of the genome, p53 accumulates and induces expression of a WAFI/CIPZ gene to produce protein p21 (13) (14) (15) ; p21 can bind to cyclinlcdk and inhibit its phosphorylation function. Because phosphorylation of Rb protein is cyclidcdk-dependent, increased accumulation of p53 protein can indirectly block the Rb protein phosphorylation process by stimulating the expression of the inhibitor p21.
The association between exposures to relatively high doses (about 1 Gy) of low linear energy transfer (LET) radiation, such as y rays, and the incidence of many solid tumors (of the lung, stomach and female breast) has been showr? clearly (16). For high-LET radiation, the carcinogenic effects of radiation dose protraction are Encertain and vary by tumcr type (17) , which indicates an organ-specific carcinogenesis process. Ullrich (18) observed a reduced carcinogenic effect for ovarian tumors in mice exposed to fission neutrons at a low dose rate relative to high dose rates with total doses up to 40 cGy. Significant enhancement of mammary tumorigenic effects of neutrons was observed after low-dose-rate or low-dose (2.5-20 cGy)
exposures. An incidence of lung tumors four times greater was evident for protracted 239Pu02 exposure, compared with a single inhalation at similar total cumulative doses in mice (19) .
The results presented here are derived from a study of 40,000 B6CF, hybrid mice (C57BU6 female x BALBk male) conducted at Argonne National Laboratory from 1971 to 1986 on the effects of acute and chronic radiation injury (20). The experiments tested many different aspects of radiation effects, inciuding single doses, protracted doses with daily or weekly wholebody exposure, and both 6oCo y-ray and 23sU fission-spectrum neutron irradiation. One of the conclusions of this study was that a higher incidence of lung adenocarcinoma was found in the BBCF, male mice exposed to protracted neutron irradiation than in those receiving the same dose in a single exposure (20) (21) (22) . Previous data from our laboratory for mice that wcre exposed to t
MATEIUALS AND METHODS
Paraffin-Embedded Tissues. Paraffin blocks containing normal lungs and lung adenocarcinomas from B K F , hybrid mice (C57BL/6 x BALB/c) that had been exposed to @' Co y-ray radiation or U fission-spectrum neutrons (0.85-MeV mean energy and 2.5% y-ray contamination) were obtained. Sham-irradiated normal lung tissues and spontaneous lung adenocarcinomas were used as controls in this study. Ten lung samples were randomly selected from each category (Table 1) . We gratefully thank B. J. Wright for her expert help on the sample selections. single-dose-irradiation demonstrated that the' 5' region of the mRb gene was deleted in 1 (17%) of 6 lung adenocarcinomas from mice exposed to y-ray irradiation in 6 (33%) of 18 spontaneous lung tumors, and in none (0%) of 6 lung adenocarcinomas from neutron-irradiated mice (23) .
The purpose of this study was to detect large gene deletions of tumor suppressor genes (mRb and p53 genes) in mice bearing lung adenocarcinomas following protracted doses of radiation. p53 gene mutations can be both early and late events in tumorigenesis. Such mutations have been considered to be an early event in lung cancer (24) .
The lung adenocarcinomas from BBCF, mice bearing niRb deletions and some normal controls were chosen for the p53 experiments. Some of the lungs had no confirmed niRb deletions when the experiment was repeated; those tissues, however, were also included in the experirncnt.
The polymerase chain reaction (PCR) was performed in a DNA thermal cycler Perkin-Elmer Cetus 480 for mRb gene fragments and PerkinElmer Cetus 9600 forp53 gene; (Norwalk, CT). All PCR reagents were purchased from PerkinElmer Cetus (Branchburg, NJ). Proteinase K was obtained from Sigma Chemical Co, (St. Louis, MO). Speed-hybridization solution (Bios; New Haven, CT) was used for prehybridization and Chemical Reagents and Equipment.
hybridization reactions. p53 primers were designed by our laboratory (T. Paunesku et al.,
Argonne National Laboratory, unpublished information). To avoid amplification of the p53 psuedogene in mice, half of the sequence from each primer contained intronic sequences to ensure that all of the PCR reactions were actually amplifying the functional p53 gene, rather than the pseudogene.
Plasmids. We thank Dr. T. P. Dryja (Harvard University, Boston, MA), who provided us with mRb cDNA plasmid probe (25); and Dr. Jane R. Pames (Stanford University Medical Center) for providing the &-microglobulin cDNA plasmid (pBRcB-3) (26). Mouse p53 plasmid was generously provided by Dr. A. J. Levine (Princeton University, Princeton, NJ) (27) . mRb cDNA Plasmid Probe Labeiing. The Nick Translation System Kit (NEK-004); DuPont, Boston, MA, was used to label the mouse Rb cDNA plasmid probe with [ u -~~P ] deoxycytidine triphosphate (dCTP)(l mCi/100 pl). The probe was counted by Probe Count (Oncor, Inc., Gaithersburg, MD), and approximately 50-100 x 106 dpm was used per 500-cm2 blot.
p53 cDNA probe was obtained by PCR amplification (with p53 primer sense 1 and antisense 9) by using mouse p53 cDNA plasmid as the DNA template, which generated a large PCR fragment (1,097 bp). Initial denaturation was at 95 "C for 5 min, followed by 30 cycles of PCR reaction: 30-min denaturation at 95 "C, 30-min annealing at 55 "C, and 1-min extension at 72 "C; the last cycle was performed at 72 "C for 7 min. This probe was labeled by using the NEN Random Primer Extension Labeling System (NEP-103L; Dupont, Boston, MA); about 50
x lo6 dpm was used per 500-cm2 blot.
PCR Procedures. Detection of mRb gene deletions was carried out by PCR, followed by Southern blot analyses. The method was adapted from previous experiments from the laboratory (23) , with fragments representing different exons (1-6) of the mRb gene. p.53 deletions were also detected by PCR and Southern blots. The initial denaturation was done at 95 "C for 5 min, followed by 40 cycles of PCR: 20-min denaturation at 94 "C, 20-min annealing at 42 "C, and 40-min extension 65 "C; the last cycle was at 65 "C for 7 min. For all experiments, for a sample to be considered as having a deleted fragment, these repetitions had to be negative by Southern blot and by comparison to control. The use of these primer pairs generates a 91-bp fragment, which can be hybridized with [a-"PIdCTP-labeled P2-M cDNA clone pBRcB-3 probe (labeled by nick translation). The PCR amplification of the P2-M gene fragment was carried out simultaneously with mRb fragments or p53 exons under the same FCR conditions. All samples failing to amplify P2-M were deleted from the study because the DNA likely was not sufficiently intact for PCR analyses.
Statistical Analyses. The statistical analyses for the data were done by one-tailed "Fisher's exact test" (2 x 2 contingency tables; Sigmastat, version 2.0). The critical value (a) was 0.05 (5% significance level).
RESULTS
mRb.
Usually, the amount of PCK product amplified from the DNA of paraffinembedded samples was not sufficient to be seen directly under UV light with ethidium bromide staining of the agarose gel. For this reason, Southern blots were chosen to detect the presence or absence of mRb bands. Figure 1 is a typical Southern blot for detection of mRb deletions.
All of the bands are the PCR products from normal lungs of mice exposed to 60 once-weekly y irradiations. Deletions were scored by monitoring the intensity of each band. Those bands with an intensity of 50% or less relative to other bands from the same tumor sample were considered deleted. Figure 1 shows a complete mRb deletion in sample S0473; partial inRb deletions in sample S0897, with fragments 2-6 being deleted, and in sample S1840, with fragments 3, 5 , and 6 being delcted; and no deletion in sample S0214. The intcrnal control gcne, Table 2 summarizes the mRb deletion data from each tested category. A significantly higher percentage of mRb deletion was found in lung adenocarcinomas from mice exposed to 60 once-weekly y irradiations (4/10; 40%), compared with those of mice exposed to 24 once-weekly y irradiations (0%) ( P = 0.043 < a = 0.05; Fisher's exact test). The results with 60 once-weekly y irradiations were not significantly different in the mRb deletion percentage from that in spontaneous lung adenocarcinomas (5/20; 25%; P = 0.431 > a = 0.05). Notably, both total dose and dose rate from 50 once-weekly pray exposures (600 cGy; 0.5 cGy/min) were higher than those from 24 once-weekly y-ray exposures (417 cGy; 0.386 cGy/min) ( Table 1 ). This could be a factor causing a higher percentage of mRb deletions in the lungs of mice exposed to the 60 once-weekly y-ray protocol. The percentage of mRb deletion in lung adenocarcinomas from mice exposed to once-weekly doses of neutron irradiation (3/10; 30%) was not significantly different compared with those of mice exposed to single-dose (0/6; 0%) ( P = 0.250) or 24 once-weekly (0110; 0%) ( P = 0.105) neutron irradiations or compared with spontaneous lung adenocarcinomas (5120; 25%) (P = 1.OOO).
For the irradiated normal lungs, no significantly different dose-rate effects were observed with regard to inRb deletion in normal lungs from mice exposed to protracted doses of radiation compared with single-dose irradiation with neutrons or y rays. The percentages of inRb deletions in normal lungs from mice exposed to 60 once-weekly neutron iindiations (3/10; 30%) wc'rc' not significantly different from the normal lungs of mice exposed to single-dose neutron irradiation (0/6, 0%; P = 0.250). The same results were also found in normal lungs from mice exposed to 60 once-weekly y irradiation (3/10; 30%) when comparing the percentages of mRb deletion in normal lungs from mice exposed to single-dose y irradiation (0%) (P = 0.250) or 24 once-weekly y irradiations (0%) (P = 0.105).
Surprisingly, no mRb deletions wcre observed in the lung adenocarcinomas of mice receiving 24 once-weekly dose of y rays or neutrons. The fact that these mice did not show at least the same mRb deletion frequency as spontaneous lung adenocarcinomas suggests that the tumorigenesis of lung adenocarcinomas from irradiated mice may involve a different mechanism. Although the mRb deletion pattern looks random throughout the gene, the deletions occurred most frequently in mRb fragments 3 (7 1%) and 5 (67%) and least frequently in mRb fragment 6 (38%).
p53. Experiments were designed to examine large p53 gene deletions in irradiated normal lungs and lung adenocarcinomas from B6CF, mice that were initially found to have deleted niRb fragments. Because later repeat experiments did not confirm some of the initial mRb deletions observed, those samples with no n7Rb deletions were also analyzed for p53 deletions.
Meanwhile, four normal lungs from sham-irradiated controls were randomly chosen for the p53 deletion study (Table 2 ).
An autoradiograph of a Southern blot to detect p53 deletions is shown in Figure 3 . The method used for scoring deletions was the same as that for the mRb gene. For example, S2123, a sample of normal lung from a mouse exposed to 60 once-weekly neutron irradiations had p.53 deletions in exon 4 (204 bp), sxon 5 (133 bp), and exon 6 (1 16 bp) and no deleticns in e x m 1 (103 bp) or exon 9 (120 bp). Sample S2363 from a spontaneous lung tumor had p53 gene deletions in exons 4 and 5 and no deletions in exons 1, 6, or 9. To ensure that all of the exons were capable of being amplified with the p53 primer pairs in this PCR reaction, B6CF, mouse DNA purified from normal fresh kidney tissue was simultaneously amplified. To control for the integrity of the DNA from each paraffin embedded sample, P,-M fragments (91 bp) were also amplified from all samples.
Deletion data on exons 1, 4, 5, 6, and 9 of the p53 gene (generated as in Figure 3 ) from all tested samples were collected and listed in Table 3 . First, p5.3 deletions were detected in 30 (97%) of 3 1 tested normal lungs and lung adenocarcinomas. Only one (sample S 1840, normal lung tissue exposed to 60 once-weekly y-ray doses) did not show any deletion in the tested exons.
Secondly, 10 (32%) of 31 had complete deletions of all exons tested; 7 ( 70%) of the 10 were from mice that had been irradiated by 60 once-weekly y-ray doses (2/8; 25%) or by 60 onczweekly neutron irradiation (5/8; 63%). For the remaining three lungs that had complete pS3 deletions, one (sample S0835) was from a sham-irradiated normal lung, and two (samples C3495 and S0762) were from spontancous lung adenocarcinomas. Third, the most frcquently de1crc.d exons were exon 4 (83%) and exon 5 (90%). Exon 9 (43%) was the least likely to be deleted among all exons studied. Finally, all samples that had no mRb deletion showed partial or complete p53 gene deletions. Only sample S1840, the normal lung of a mouse receiving 60 once-weekly y-ray doses had mRb deletion (fragments 3,5, and 6 ) with the p53 gene intact. A significant difference in the deletion percentage of the mR6 gene was found for lung adenocarcinomas from mice receiving 60 once-weekly y-ray doses (40%) when compared to those receiving 24 once-weekly y-ray doses (0%; P < 0.05); however, the percentage in those receiving 60 once-weekly y irradiation was not significantly different from that of mice that had received single-dose y-ray exposure (17%), nor from that in spontaneous lung adenocarcinomas (25%; P > 0.05) ( Table 2 ). This significant difference could be attributed to the higher total dose and dose rate (600 cGy; 0.5 cGy/min) in the 60 once-weekly y-ray doses than the total dose and dose rate (417 cGy; 0.368 cGy/min) in the 24 once-weekly y-ray exposurcs. According to Grahn P I al. (22) , the incidence of spontaneous lung adenocarcinomas in BGCF, male mice was very high (fist occurrence around 200 days of age, and a frequency of 53% in 800-day-old control males), but the prevalence of lung adenocarcinoma was even greater in irradiated mice. Thus, some of the mRb gene deletions may be the result of spontaneous alterations.
DISCUSSION
On the contrary, the normal lungs of mice receiving protracted doses of neutrons did not have statistically signXicant (P : 0.05) mRb deletion frequencies (20% ir. 24 onceweekly neutron irradiation; 30% in 60 once-weekly neutron irradiation), compared with those of mice exposed to single-dose neutron irradiation (0%) ( Table 2 ). The experiments were designed so that normal lungs of mice receiving 24 once-weekly neutron doses were compared with those of mice receiving single-dose neutron exposure at the same total dose (60 cGy), so the differences in mRb deletion frequency may be attributed to dose protraction. Notably, normal lungs of mice receiving 60 once-weekly neutron doses had a lower totzl dose (40 cGy) than the 24 once-weekly neutron or the single-dose neutron exposures but have shown the highest nzRb deletion frequencies (30%) among these three groups.
The histopathologic data (Table 3) also revealed the possible involvement of lymphoma in the lungs. For example, sample S0835, a normal lung from a sham-irradiated control, indicated a frequency (l/lO; 10%) of rnRb deletion that could be caused by the presence of undetected lymphoma in the lung. Similarly, no nzRb deletions were observed in the normal lungs from mice exposed to a single-dose y irradiation or to 24 once-weekly irradiation, while 30% of the normal lungs of mice receiving 60 once-wcckly y irradiation showcd riiRb deletions.
However, the percentage in mice receiving 60 once-weekly y irradiation was not significantly different compared with normal lungs exposed to single-dose y irradiation or 24 once-weekly y irradiation.
Radiation Quality: y-ray vs. Neutron Radiation. The data from Table 3 demonstrate a difference in the ?nRb deletion spectrum in mice receiving different qualities of radiation.
Comparisons of the percentztges of complete deletions of mRb genes in normal lungs and lung adenocarcinomas from mice receiving protracted y rays (3/7; 43%) with those receiving protracted neutrons (1/8; 13%) have shown that protracted y-ray doses tend to produce a higher percentage of mRb deletions than those of protracted neutrons. This fact is surprising because high-LET neutron radiation is commonly reported to induce more large gene deletions than low-LET y rays (31). Estimates of DNA damage by different qualities of radiation have revealed that a single y-ray track produced an average of one single-strand break (ssb), but high-LET a particles produced 200 ssb. y-Rays produced 0.04 double-strand breaks (dsb), and an a particle produced 35 dsb (a neutron should be between these two values) (32). High-LET radiation can deposit very large numbers of ionizations within a short stretches of DNA, inducing qualitatively different types of damage than those commonly found from low-LET radiation (33). The damage caused by high-LET radiation is often very great and much more difficult to repair than that from low-LET radiation (31,34); however, there are exceptions for a few genes, such as hprt gene mutations in hamster cells, in which no differences in the high-vs. low-LET mutation spectrum were observed (35,361. showed that all mRb deletions were at the 5' end of the gene (fragments 1-3), our data demonstrate deletions throughout the whole gene, with the highest deletion frequencies in fragments 3 (71%) and 5 (67%) and the lowest in fragment 6 (38%). According to Kaelin et al. showed that 16 (27%) out of 60 primary lung tumors had telomere length alterations, and 10 (63%) of 16 had allelic loss of both the pS3 and R b genes. Therefme, the increased incidence of lung adenocarcinoma incidence in irradiated BWF, male mice may be due to other mechanisms, such as p.53 alteration or some oncogene activation. mRb gene deletion may play a role by combining with p53 alterations to accelerate lung tumorigenesis. More recent work from our laboratory has demonstrated that the reported Ile on codon 234 in the C57BW6 mouse is actually an oncogenic change associated with the transformed SVT2 cell line (70). Thus, the core domain of p53 was evolutionarily conserved among the species.
While a point mutation was the predominant type of p53 alteration, our data demonstrate that the major large gene deletion in p53 occurs within its central core domain. In fact, many investigztors have reported p53 deletions in both human and mouse tumors, such as urothelial tumors, bladder cancer, hepatocellular carcinomas, and mouse skin and bone tumors (47-49).
Human lung tumors had a high frequency of p53 mutations in small-cell lung cancer (70% and, non small-cell lung cancer (47%, including 33% in adenocarcinomas) (29, 50) .
Differences in radiation quality were also observed from the p53 deletion data ( Table 3 ).
All of the complete deletions of the p53 gene occurred in the normal lungs and lung adenocarcinomas from mice exposed to 60 once-weekly y or 60 once-weekly neutron irradiations.
Among these mice, the ones exposed to 60 once-weekly neutron irradiations (5/8; 63%) had a higher percentage of complete deletions than did mice exposed to 60 once-weekly y irradiations (2/8; 25%) or spontaneous lucg adenocarcinonias (2/6; 33%). Similariy, spontaneous lung adenocarcinomas had both complete (2/6; 33%) and partial (4/6; 67%) p53 deletion. Among these mice, exon 4 (4/6; 67%), exon 5 (6/6; loo%), and exon 6 (4/6; 67%) were the most frequently deleted exons.
Many studies in the literature show p53 deletions following radiation exposure. For example, Boice et al. (51) observed an increased incidence of breast cancer following diagnostic or therapeutic radiation. In another study using fractionated y-ray irradiation at a clinically used dose (total dose of 30 Gy), the normal human mammary epithelial cell was transformed, and those transformed cells showed a complete lack of p53 protein, deletion of one allele of the p53 gene, and a 26-bp deletion in the third intron of the other allele (52). Ootsuyama et al. (53) reported that 20 (31%) out of 65 tumors had p53 mutations; 11 (55%) of the 20 were minute deletions in the cDNA of p53 from repeated 90Sr-90Y P-irradiated mouse skin and bone tumors.
In contrast to our findings, Thraves et al. (54) showed that cellular p53 (exons 4-9) and ras gene mutations were not involved in the transformation of immortalized human epithelial cells to a malignant phenotype by single-dose fission-neutron irradiation. Because our study used tissues from mice exposed to protracted doses, the p53 deletion frequency could be expected to be different when compared with that of lungs from mice exposed to single-dose irradiation.
Limitations of the Assays. The reason for using Southern blot analyses in these experiments was the difficulty of obtaining an adequate amount of PCR products from the paraffin blocks for direct gel analyses. Combining PCR with Southern blotting made it possible to observe rather easily the limited amount of mRb gene PCR product through autoradiography.
Nevertheless, some limitations in the mRb deletion detection assay, are unavoidable as indicated by Churchill et al. (23) . In particular, this assay only detected part of the whole 17iRb gene; the information about introns and the regions between those fragments were not included in this study.
Our p53 assay also has certain limitations: (1) The studies of large p53 deletions were performed only on lungs and lung adenocarcinomas that were initially found to be bearing mRb deletions. We did not carry out a study of p53 deletion independent of mRb deletions. (2) Only a few of the shamirradiated normal lungs were included in this test; dl were found tc have p53 deletions (' Table 2 
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Data from Churchill et al. (23) . Not significantly different from normal lungs receiving 60x1 sham-irradiation (P = 0.582 > a = 0.05; Fisher's exact test) or 1x1, n irradiation ( P = 0.250) or 24xl,n irradiation (P = 1 .Ooo).
Not significantly different from lung adenocarcinomas of mice exposed to lx1,n irradiation (P = 0.250), 24x 1 ,n irradiation (P = 0.105), or spontaneous lung
Not significantly different from normal lungs of mice exposed to 1 x 1 ,~ (P = 0.250) OR 24x 1 ,y irradiation ( P = 0.105). e Significantly different from lung adenocarcinomas of mice exposed to 24x 1, y irradiation (P = 0.043 < a = 0.05) but not significantly different from spontaneous lung adenocarcinomas (P = 0.431).
d shows a typical pattern of six mRb gene fragments; sample SO473 shows a complete inRb gene deletion; and the mHb gene in samples SO897 (fragments 2-6), and S1840 (fragments 3, 5. and 6) is partially deleted. lane 2: P2-M fragment amplified from P2-M plasmid; lanes 3-10: P,-M fragments amplified from lung adenocarcinomas from mice exposed to 24 once-weekly 6oCo y-ray doses (Le., C2309, C2025, C1788, C1570, C1343, C1314, C1021, and CO310, respectively). 
